These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3458712)

  • 1. Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells.
    Speth PA; Linssen PC; Boezeman JB; Wessels JM; Haanen C
    J Chromatogr; 1986 Apr; 377():415-22. PubMed ID: 3458712
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids.
    Oosterbaan MJ; Dirks RJ; Vree TB; van der Kleijn E
    J Chromatogr; 1984 Mar; 306():323-32. PubMed ID: 6585367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline assay by high-pressure liquid chromatography.
    Averbuch SD; Finkelstein TT; Fandrich SE; Reich SD
    J Pharm Sci; 1981 Mar; 70(3):265-9. PubMed ID: 6943332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
    Ehninger G; Stocker HJ; Proksch B; Wilms K
    Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of circulating 7-deoxyaglycone metabolites of 4'-deoxydoxorubicin in man.
    Cummings J; Kerr DJ; Kaye SB
    Cancer Chemother Pharmacol; 1987; 20(3):263-4. PubMed ID: 3677300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decomposition of mitomycin and anthracycline cytostatics in cell culture media.
    Beijnen JH; Van der Nat JM; Labadie RP; Underberg WJ
    Anticancer Res; 1986; 6(1):39-43. PubMed ID: 3082277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicinolone formation and efflux: a salvage pathway against epirubicin accumulation in human heart.
    Salvatorelli E; Menna P; Lusini M; Covino E; Minotti G
    J Pharmacol Exp Ther; 2009 Apr; 329(1):175-84. PubMed ID: 19144686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic study of methotrexate and the anthracyclines].
    Lokiec F; Najean Y; Kadouche J
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXV. PubMed ID: 296375
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution.
    Beijnen JH; Wiese G; Underberg WJ
    Pharm Weekbl Sci; 1985 Jun; 7(3):109-16. PubMed ID: 3860797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells.
    Ando S; Nakamura T; Kagawa D; Ueda T; Nishimura T; Kubo A; Tsutani H; Sasada M; Uchino H
    Cancer Treat Rep; 1986 Jul; 70(7):835-41. PubMed ID: 3459574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid quantitative determination of doxorubicin and its metabolites in biological samples.
    Sqalli A; Labat C; Oustrin J; Houin G; Coulais Y; Bugat R; Carton P
    Ann Biol Clin (Paris); 1989; 47(2):63-6. PubMed ID: 2735565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum.
    Cummings J; Milstead R; Cunningham D; Kaye S
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):991-1001. PubMed ID: 3770056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin levels in the serum and ascites of patients with ovarian cancer.
    Gotlieb WH; Bruchim I; Ben-Baruch G; Davidson B; Zeltser A; Andersen A; Olsen H
    Eur J Surg Oncol; 2007 Mar; 33(2):213-5. PubMed ID: 17174514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine metabolism and disposition of marcellomycin.
    Dodion P; Egorin MJ; Tamburini JM; Riggs CE; Bachur NR
    Drug Metab Dispos; 1984; 12(2):209-16. PubMed ID: 6144487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracenedione activation by NADPH-cytochrome P-450 reductase; comparison with anthracyclines.
    Kharasch ED; Novak RF
    Biochem Pharmacol; 1981 Oct; 30(20):2881-4. PubMed ID: 6274352
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial biotransformations of daunorubicin to aglycones by rat liver microsomes.
    Schwartz HS; Parker NB
    Cancer Res; 1981 Jun; 41(6):2343-8. PubMed ID: 7237433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytofluorescence localization of anthracycline antibiotics.
    Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
    Cancer Res; 1980 Dec; 40(12):4669-76. PubMed ID: 6934029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.